Objective: This paper investigated the effects of STAT3 through promoting FOXP1 transcription on proliferation, apoptosis and invasion in glioma cells.
| INTRODUCTION
Glioma is one of the most prevalent intracranial malignancies and characterized as invasive growth without obvious boundaries distinguishing from adjacent brain tumour tissues.
1 Despite the significantly enhanced diagnosis and therapy for glioma including excision, radiation therapy and chemical therapy, the prognosis of glioma remains unfavourable because of its cell proliferation and invasion into the adjacent normal brain parenchyma. [2] [3] [4] [5] [6] [7] Furthermore, due to the invasive nature of high-grade glioma, the 5-year survival rates of high-grade glioma patients are <10%. 8 Although some studies have been carried out on the prognostic significance of glioma, it will be highly desirable to determine the molecular mechanisms for the glioma therapy that will be more effective for patients. 5, 9 Signal Transducer and Activator of Transcription 3 (STAT3), a member of the STAT protein family, has played a vital role in Xinlin Sun and Jihui Wang contributed equally to this work.
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transmitting signals form cytokines and growth factors. 10, 11 The activation of the STAT3 protein is composed of a chain of events including dimerization of the N-terminal domain, then Src Homology 2 (SH2) domain, the subsequent DNA-binding domain and the final transcription activation of the C-terminal domain. [12] [13] [14] SH2 domain and the transcription activation are of great significance for STAT3 activation. 13 However, STAT3 is constantly activated in a wide range of human malignant tumours including glioma. [15] [16] [17] [18] And once activated, STAT3 is associated with oncogenesis and cancer progression through promoting the transcription of a few genes which control tumour cell viability, and inhibit cell apoptosis, vascularization and cell cycle. [19] [20] [21] [22] To be more specific, the constitutively activated STAT3 elevates the expression of the downstream gene including
Bcl-2, Bcl-xl, c-myc, survivin and vascular endothelial growth factor (VEGF). [23] [24] [25] Forkhead box protein P1 (FOXP1), a member of FOXP subfamily, is a transcriptional factor that has extensive functions. 26 The FOXP subfamily is part of FOX proteins superfamily which has a highly preserved "fork-head" DNA-binding domain. 27 FOX proteins mediate cell-division cycle, cell viability, differentiation and apoptosis.
28
FOXP1 serves as both potential oncogene and tumour suppressor due to its distinguishing expression levels in diverse tumour types. 29 On the one hand, FOXP1 was reported to be an oncogene with overexpressed mRNA levels and protein levels of various human Bcell lymphomas. [30] [31] [32] [33] [34] On the other hand, silencing of FOXP1 has been associated with prostate cancer, renal cell cancer and breast cancer. [30] [31] [32] 35, 36 Findings of the molecular mechanism of oncogenesis and progression of glioma are vital to ameliorate present treatments and develop new therapy. Up to now, however, the associations between STAT3 and FOXP1 expression in human glioma have not been examined. Our findings facilitate the perception of molecular mechanism and effects of STAT3 on glioma progression via inducing FOXP1 and usher in a novel therapy for gliomagenesis.
| MATERIALS AND METHODS

| Tissue samples and clinical characteristics
All glioma tissue samples were gained from a total of 71 patients undergoing operative treatment at the Zhujiang Hospital, Southern
Medical University, after they signed the written informed consent.
In total, 71 glioma tissues and 71 adjacent glioma tissues were stored frozen at −80°C until for the use of qPCR or western blot measurement. The current study was confirmed by the Ethics Committee of Zhujiang Hospital, Southern Medical University. Clinical characteristics were seen in Table 1 . 
| Cell culture
| Cell transfection
The U87 and SHG-44 cells transfection were conducted by Lipofec- These experiments were repeated twice. CTCTTTAGGCTGTTTTCCAGCAT-3′; GAPDH forward: 5′-GAAGGT-GAAGGTCGGAGTC-3′, GAPDH reverse: 5′-GAAGATGGTGATGG-GATTTC-3′.
| Western blot
Total proteins were isolated from the cell lines. 
| Luciferase reporter assays
| Chromatin immunoprecipitation assays
The chromatin immunoprecipitation (ChIP) assay kit was purchased through Upstate Biotechnology (Lake Placid, NY, USA 
| MTT assay
Briefly, U87 or SHG-44 cells were grown in 96-well dishes at 37°C.
Measurements were divided into four groups including NC group, siRNA1-STAT3 group, pcDNA3.1-FOXP1 and siRNA1-STAT3 + p- 
| Colony formation assays
In total, 1 × 10 3 U87 or SHG-44 cells were placed in six-well plates and incubated at 37°C. After transfection, living cells were detected via trypan blue staining and calculated. A lower number of viable cells were then planted in 6-well dishes and went on incubation for 2-3 weeks. Subsequently, cells were rinsed with phosphate-buffered saline (PBS) buffer and set with methanol. Crystal violet with methanol was used to stain transfected U87 cells for 10 minutes at room temperature. Finally, distilled water was used to wash and dry the plates. Each measurement was run in triplicate.
| Flow cytometry
Cell apoptosis rate was caculated by flow cytometry assay. Experiments were randomly divided into NC group and transfected groups including siRNA1-STAT3 group, pcDNA3.1-FOXP1 and siRNA1-STAT3 + p-FOXP1 group. After collection, cells were rinsed and resuspended with PBS. Then Annexin V-FITC/PI Apoptosis Detection Kit (BD Biosciences, San Jose, CA, USA) was used to stain cells as described in manufacturer's protocol. FACS Calibur (BD Biosciences) was run to determine the apoptosis rate of the stained cells. Data were measured by FACS Diva software. These experiments were repeated 3 times.
| Invasion assays
Transwell units were used to conduct the cell invasion assays. The upper chamber membranes were coated with matrigel and the lower chamber was supplemented with FBS. After 48-hour incubation, the SUN ET AL.
| 
| Statistical analysis
The significance of the data between experimental groups was measured by Student t test, using GraphPad Prism 6.0 (GraphPad Prism; Version X; La Jolla, CA, USA). P < 0.05 was regarded as of statistical Figure 1D ). Meanwhile, western blot analysis showed that STAT3 protein levels in glioma cell lines (SHG-44, U87, GOS-3 and TJ905) were higher than normal human astrocyte (SVG P12 and HA) ( Figure 1E and F) . In addition to that, among the human glioma cells including SHG-44, U87, GOS-3 and TJ905, U87 and SHG-44 were with the highest and the second highest mRNA and protein levels of STAT3, respectively, which were selected as the main experimental subject.
| STAT3 activated FOXP1 expression by binding to its promoter region
Some reports documented that FOXP1 was closely correlated with human glioma progression. 37 However, the association between Then qRT-PCR analysis revealed that mRNA levels of STAT3 and FOXP1 were simultaneously down-regulated in groups of siRNA1-STAT3 and siRNA2-STAT3 compared with NC group (Figure 2A and B). Western blot analysis revealed that the protein levels of STAT3 F I G U R E 1 STAT3 was highly expressed in glioma tissues and cells. A, The STAT3 expression levels in adjacent and tumour glioma tissues were analysed by qRT-PCR. ***P < 0.001, compared with adjacent tissues. B-C, The STAT3 protein levels in adjacent and tumour glioma tissues were analysed by western blot assay. GAPDH was regarded as an internal control. n = 10, ***P < 0.001, compared with adjacent tissues. D, Relative STAT3 expression levels was detected in astrocyte cells (SVG P12 and HA) and glioma cell lines (SHG-44, U87, GOS-3 and TJ905) by qRT-PCR. **P < 0.01, compared with SVG P12; # P < 0.05 and ## P < 0.01, compared with HA. (E-F) Relative STAT3 protein levels were observed in SVG P12, HA, SHG-44, U87 and GOS-3 and TJ905 cell lines by western blot assay. **P < 0.01, compared with SVG P12; Figure 3C and D) . Besides, the inhibition effects of siRNA1-STAT3 were stronger than siRNA2-STAT3. Therefore, siRNA1-STAT3 was selected to continue the next experiments. In short, STAT3 was the transcriptional regulator of FOXP1.
| STAT3 promoted glioma cell proliferation through promoting FOXP1 transcription
To determine whether STAT3 promoted glioma progression via Therefore, STAT3 enhanced cell invasive ability by inducing FOXP1.
| DISCUSSION
Related reports had revealed that STAT3 expressions were associated with prognosis of diverse types of tumours such as breast cancer, acute myelogenous leukaemia and glioma, among others. [38] [39] [40] Previously, a few studies had reported the overexpression of STAT3
in certain cancer types including intrahepatic cholangiocarcinoma, breast cancer and high-grade glioma. 18, 41, 42 Additionally, Carro et al 43 reported a relationship between STAT3 expression and the mesenchymal transformation of glioma, suggesting that STAT3 was a "master regulator" of glioma transformation. In view of this, we hypothesized that STAT3 overexpression is associated with glioma.
As expected, our findings demonstrated that STAT3 expression levels were elevated at both mRNA and protein levels in human glioma tissues and cells. and FOXP1 may be underlying therapeutics for glioma.
CONFLI CT OF INTEREST
The authors confirm that there are no conflicts of interest.
O R C I D
Xinlin Sun
http://orcid.org/0000-0003-4195-3038 
R E F E R E N C E S
